These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


376 related items for PubMed ID: 478273

  • 1. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 2. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 3. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 4. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 5. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 6. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY, Saxena BB, Landesman R.
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [Abstract] [Full Text] [Related]

  • 7. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB, Granai CO, Ball HG, Curry SL.
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [Abstract] [Full Text] [Related]

  • 8. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 9. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 10. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

  • 11. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun 20; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 12. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 20; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 13. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK, Gokel JM, Holzmann K.
    Arch Gynecol; 1979 Jul 20; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract] [Full Text] [Related]

  • 14. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M, Berkowitz R, Goldstein D, Bellet D, Wands JR.
    Am J Obstet Gynecol; 1988 Jan 20; 158(1):193-8. PubMed ID: 2447774
    [Abstract] [Full Text] [Related]

  • 15. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H, Neri A, Bar J, Regev D, Nordenberg J, Ovadia J.
    Obstet Gynecol; 1993 Oct 20; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [Abstract] [Full Text] [Related]

  • 16. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct 20; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 17. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI.
    Gynecol Oncol; 2000 Jul 20; 78(1):39-42. PubMed ID: 10873407
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Jul 20; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 19. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I, Vejerslev LO, Frøding L, Blaakær J, Maroun LL, Hansen ES, Grove A, Lund H, Havsteen H, Sunde L.
    Dan Med J; 2015 Nov 20; 62(11):A5082. PubMed ID: 26522484
    [Abstract] [Full Text] [Related]

  • 20. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K, Satgunasingam N, Nasri NM, Ng KY.
    Med J Malaysia; 1993 Mar 20; 48(1):40-5. PubMed ID: 7688063
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.